Ariel Miller
Overview
Explore the profile of Ariel Miller including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
98
Citations
2002
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Skvirsky S, Winer Z, Baratz S, Barsha H, Younes G, Miller A, et al.
Reprod Biomed Online
. 2024 Jun;
49(3):103980.
PMID: 38897135
Research Question: Is fertility affected in women with multiple sclerosis (MS), and what is their usage of assisted reproductive technology (ART)? Design: Data regarding multiple sclerosis and ART usage among...
2.
Neter E, Esterkin-Hubner E, Glass-Marmor L, Wolkowitz A, Lavi I, Miller A
Patient Prefer Adherence
. 2024 Jun;
18:1195-1203.
PMID: 38895639
Purpose: To evaluate the acceptability, retention, and efficacy of face-to-face intervention, incorporating education and Motivational Interviewing (MI) to support persons with relapsing-remitting multiple sclerosis (PwRRMS) and increase self-reported medication adherence....
3.
Kugelman N, Staun-Ram E, Volkovitz A, Barnett-Griness O, Glass-Marmor L, Miller A
Mult Scler Relat Disord
. 2024 May;
87:105604.
PMID: 38718750
Background: Multiple Sclerosis (MS) may cluster in families, an entity known as familial MS (FMS), possibly due to aggregation of genetic and environmental factors. Though previous studies have characterized FMS...
4.
Nitzan Z, Staun-Ram E, Volkowich A, Miller A
Int J Mol Sci
. 2023 Oct;
24(19).
PMID: 37834472
Microbiome dysbiosis is increasingly being recognized as implicated in immune-mediated disorders including multiple sclerosis (MS). The microbiome is modulated by genetic and environmental factors including lifestyle, diet, and drug intake....
5.
Neter E, Miller A
Int J MS Care
. 2023 Sep;
25(5):206-213.
PMID: 37720261
Background: Up to 50% of individuals with multiple sclerosis (MS) who are prescribed disease-modifying treatments (DMTs) do not take them as advised. Although many studies report on DMT adherence rate,...
6.
Neter E, Glass-Marmor L, Wolkowitz A, Miller A
Mult Scler Relat Disord
. 2022 Oct;
68:104224.
PMID: 36242806
Background: Though habitual behavior is part of medication-taking behavior, studies of adherence to medication among persons with relapsing remitting multiple sclerosis (PwRRMS) have not prospectively examined habit in relation to...
7.
Milo R, Staun-Ram E, Karussis D, Karni A, Hellmann M, Bar-Haim E, et al.
Front Immunol
. 2022 Apr;
13:868915.
PMID: 35432335
Background: Immunomodulatory/immunosuppressive activity of multiple sclerosis (MS) disease modifying therapies (DMTs) might affect immune responses to SARS-CoV-2 exposure or vaccination in patients with MS (PwMS). We evaluated the effect of...
8.
Neter E, Glass-Marmor L, Haiien L, Miller A
Patient Prefer Adherence
. 2021 May;
15:939-943.
PMID: 33994780
Background: As the number of treatment options for multiple sclerosis (MS) has expanded, alignment between physician and patient on effects of medication has emerged as important for medication persistence/discontinuation. Objective:...
9.
Golan D, Sagiv S, Glass-Marmor L, Miller A
PLoS One
. 2021 May;
16(5):e0250647.
PMID: 33951061
Background: The applicability of mobile digital technology to promote clinical care of people with multiple sclerosis (pwMS) is gaining increased interest as part of the implementation of patient-centered approaches. We...
10.
Neter E, Glass-Marmor L, Wolkowitz A, Lavi I, Miller A
BMC Neurol
. 2021 Mar;
21(1):136.
PMID: 33761887
Background: Though adherence to disease-modifying therapies (DMTs) among persons with multiple sclerosis (PwMS) varies and is often below 80%, only few prospective studies on adherence examined predictors beyond demographic and...